What is happening with Precision BioSciences Inc. (DTIL) Stock?

BMO Capital Markets raised the price target for the Precision BioSciences Inc. (NASDAQ:DTIL) stock to ‘an Outperform’. The rating was released on June 17, 2023, according to finviz. The research report from BTIG Research has resumed the stock to Buy, with a price target set at $16. The stock was downgraded by Goldman, who disclosed in a research note on April 03, 2020, from Buy to Neutral and set the price objective to $7. In their research brief published March 05, 2020, Stifel analysts initiated the Precision BioSciences Inc.